Treatment of systemic lupus erythematosus
- 30 June 2001
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 1 (6), 1065-1075
- https://doi.org/10.1016/s1567-5769(01)00037-6
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosusArthritis & Rheumatism, 1999
- Prolactin, a pituitary hormone that modifies immune responsesLupus, 1998
- Bone marrow transplantation in the treatment of autoimmune diseases: evolving concepts and early experienceLupus, 1997
- Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patientsRheumatology, 1997
- Sequential Therapy for Diffuse Proliferative and Membranous Lupus Nephritis: Cyclophosphamide and Prednisolone Followed by Azathioprine and PrednisoloneNephron, 1995
- Treatment of proliferative lupus nephritis with methylprednisolone pulse therapy and oral azathioprineThe Netherlands Journal of Medicine, 1995
- Thalidomide for systemic lupus erythematosusThe Lancet, 1992
- Therapy of Lupus NephritisNew England Journal of Medicine, 1986
- Effect of Treatment on the Evolution of Renal Abnormalities in Lupus NephritisNew England Journal of Medicine, 1984
- Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and CyclophosphamideNew England Journal of Medicine, 1978